ENVUE MEDICAL INC NEW
FEED
FEED was delisted on the 15th of September, 2026.
9 hedge funds and large institutions have $2.12M invested in ENVUE MEDICAL INC NEW in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
23% more capital invested
Capital invested by funds: $1.72M → $2.12M (+$394K)
0.61% more ownership
Funds ownership: 5.92% → 6.53% (+0.61%)
18% less funds holding
Funds holding: 11 → 9 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$204K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$113K |
| 3 |
Millennium Management
New York
|
+$22.7K |
| 4 |
State Street
Boston,
Massachusetts
|
+$22.7K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$22.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$90.6K |
| 2 |
Goldman Sachs
New York
|
-$64K |
| 3 |
Renaissance Technologies
New York
|
-$45.3K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$22K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$16K |
FEED Hedge Fund Activity: Q1 2022 in Review
9 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q1 2022, worth a combined $2.12M — up 23% from $1.72M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of FEED and 3 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Vanguard Group, adding an estimated $204K. The largest seller was Morgan Stanley, exiting entirely with an estimated $90.6K sold.
- 9 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q1 2022, down from 11 in Q4 2021.
- Funds reported $2.12M of ENVUE MEDICAL INC NEW stock for Q1 2022, up 23% quarter-over-quarter.
- 3 funds opened new ENVUE MEDICAL INC NEW positions in Q1 2022 and 5 closed out, a net change of -2 holders.
- The largest ENVUE MEDICAL INC NEW buyer in Q1 2022 was Vanguard Group, an estimated $204K added.
- The largest ENVUE MEDICAL INC NEW seller in Q1 2022 was Morgan Stanley, an estimated $90.6K sold.
Based on aggregated 13F filings for Q1 2022.